North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the NOSE Study is to carefully examine the efficacy and safety of 3 nasal
sprays (bevacizumab, estriol, and tranexamic acid), compared to placebo, for the treatment of
HHT related nosebleeds.
Phase:
Phase 2
Details
Lead Sponsor:
James Gossage
Collaborators:
Hereditary Hemorrhagic Telangiectasia Foundation International HHT Foundation International